Inhaled Technosphere Insulin
Phase 2/3Recruiting 0 views this week 0 watching💤 Quiet
Interest: 39/100
39
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetes, Gestational
Conditions
Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders, Glucose Intolerance During Pregnancy
Trial Timeline
May 1, 2025 → Jul 1, 2025
NCT ID
NCT06535789About Inhaled Technosphere Insulin
Inhaled Technosphere Insulin is a phase 2/3 stage product being developed by MannKind Corp for Diabetes, Gestational. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06535789. Target conditions include Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders.
What happened to similar drugs?
20 of 20 similar drugs in Diabetes, Gestational were approved
Approved (20) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
15
Activity
15
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06535789 | Phase 2/3 | Recruiting |
Competing Products
20 competing products in Diabetes, Gestational